Cargando…
Medullary thyroid cancer: molecular factors, management and treatment
Medullary thyroid cancer (MTC) is an infrequent neuroendocrine tumor, which amounts to 3–5% of all thyroid malignancies. Approximately 75–80% of MTCs are sporadic neoplasms. The rest of 20–25% are familial cases that belong to multiple endocrine neoplasia (MEN) syndromes, specifically MEN2 and MEN3....
Autores principales: | Pavlidis, Efstathios, Sapalidis, Konstantinos, Chatzinikolaou, Fotios, Kesisoglou, Isaak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112777/ https://www.ncbi.nlm.nih.gov/pubmed/33817709 http://dx.doi.org/10.47162/RJME.61.3.06 |
Ejemplares similares
-
A Rare Coexistence of Medullary Thyroid Cancer with Graves Disease: A Case Report and Systematic Review of the Literature
por: Sapalidis, Konstantinos, et al.
Publicado: (2019) -
A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC)
por: Passos, Ioannis, et al.
Publicado: (2021) -
Be(a)ware of Leukocytosis in Papillary Thyroid Cancer
por: Laskou, Styliani, et al.
Publicado: (2022) -
Modern aspects of the management of pancreatic intraductal papillary mucinous neoplasms: a narrative review
por: Pavlidis, Efstathios T., et al.
Publicado: (2022) -
Small bowel obstruction as a result of an obturator hernia: a rare cause and a challenging diagnosis
por: Pavlidis, Efstathios, et al.
Publicado: (2018)